CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-12-22 | POYHONEN JOHN Director | Grant or award · Stock Option (Right to Buy) | +19,500 | 19,500 | ||
| 2015-12-22 | MANHARD KIMBERLY Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2015-12-22 | Johnson Craig A Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2015-12-22 | Rosen Robert President | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2015-12-22 | Quart Barry D Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2015-12-22 | Marshall Paul SVP, Technical Operations | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2015-12-22 | Drazba Brian G. VP, Finance & CFO | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2015-10-30 | Drazba Brian G. VP, Finance & CFO | Other acquisition | +714 | $9.36 | $7K | 2,683 |
| 2015-10-14 | Quart Barry D Chief Executive Officer | Exercise or conversion | +10,000 | $7.20 | $72K | 80,055 |
| 2015-10-14 | Quart Barry D Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 940,694 | ||
| 2015-10-12 | Clendeninn Neil James SVP & Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2015-10-12 | Clendeninn Neil James SVP & Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2015-09-29 | Quart Barry D Chief Executive Officer | Exercise or conversion | +14,306 | $7.20 | $103K | 70,055 |
| 2015-09-29 | Quart Barry D Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −14,306 | 950,694 | ||
| 2015-08-18 | Quart Barry D Chief Executive Officer | Exercise or conversion | +10,000 | $7.20 | $72K | 55,749 |
| 2015-08-18 | Quart Barry D Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 965,000 | ||
| 2015-06-20 | Quart Barry D Chief Executive Officer | Other acquisition | +600 | 600 | ||
| 2015-06-10 | TANG KEVIN C Director | Purchase | +121,212 | $24.75 | $3.0M | 4,867,530 |
| 2015-06-02 | MANHARD KIMBERLY Director | Exercise or conversion | +10,500 | $8.80 | $92K | 10,500 |
| 2015-06-02 | MANHARD KIMBERLY Director | Sale | −10,500 | $23.58 | $248K | 0 |
Page 37 of 38 · 746 trades